Pimobendan is a veterinary medication and benzimidazole-pyridazinone derivative that functions as a calcium sensitizer and phosphodiesterase-3 inhibitor to manage congestive heart failure in dogs. This… Read more
![Chemical structure of 6-(2-(4-Methoxyphenyl)-1-nitroso-1H-benzo[d]imidazol-5-yl)-5-methyl-4,5-dihydropyridazin-3(2H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F6-2-4-Methoxyphenyl-1-nitroso-1H-benzodimidazol-5-yl-5-methyl-45-dihydropyridazin-32H-one.png&w=3840&q=75)


















Pimobendan is a veterinary medication and benzimidazole-pyridazinone derivative that functions as a calcium sensitizer and phosphodiesterase-3 inhibitor to manage congestive heart failure in dogs. This category provides essential Pimobendan reference standards, including the active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, and stable isotope-labelled compounds. Laboratories utilize these materials for critical analytical tasks, including method development, validation, and routine quality control. By facilitating accurate impurity profiling and stability studies, these compounds support compliance with rigorous regulatory and pharmacopeial specifications. Researchers also rely on stable isotope-labelled derivatives as internal standards in quantitative analysis, enabling the precise identification and monitoring of metabolites and degradation products formed through oxidative or hydrolytic pathways. These materials are foundational for ensuring the characterization and assessment of this therapeutic agent in veterinary pharmaceutical research and development.